Evaxion Biotech A/S: Evx-01, Triggered a Specific and Tumor-Targeting Immune Response in All Assayed Melanoma Patients
Evaxion生物科技EVX-01,在所有檢測的黑色素瘤患者中觸發了特定和靶向腫瘤的免疫反應。
Evaxion Biotech A/S: Evx-01, Triggered a Specific and Tumor-Targeting Immune Response in All Assayed Melanoma Patients
Evaxion生物科技EVX-01,在所有檢測的黑色素瘤患者中觸發了特定和靶向腫瘤的免疫反應。
譯文內容由第三人軟體翻譯。